Barry I. Posner

19.4k total citations · 2 hit papers
230 papers, 13.4k citations indexed

About

Barry I. Posner is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cell Biology. According to data from OpenAlex, Barry I. Posner has authored 230 papers receiving a total of 13.4k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Molecular Biology, 76 papers in Endocrinology, Diabetes and Metabolism and 45 papers in Cell Biology. Recurrent topics in Barry I. Posner's work include Metabolism, Diabetes, and Cancer (54 papers), Growth Hormone and Insulin-like Growth Factors (50 papers) and Pancreatic function and diabetes (42 papers). Barry I. Posner is often cited by papers focused on Metabolism, Diabetes, and Cancer (54 papers), Growth Hormone and Insulin-like Growth Factors (50 papers) and Pancreatic function and diabetes (42 papers). Barry I. Posner collaborates with scholars based in Canada, United States and France. Barry I. Posner's co-authors include John Bergeron, H. Guyda, Mark van Houten, Paul A. Kelly, Henry G. Friesen, Masood N. Khan, François‐Jérôme Authier, Raymond J. Walsh, I. George Fantus and Paul G. Drake and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Barry I. Posner

228 papers receiving 12.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Studies of Insulin, Growth Hormone and Prolactin Binding: Tissue Distribution, Species Variation and Characterization

1974 509 citations Barry I. Posner et al. Endocrinology profile →
Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics.

1994 479 citations Barry I. Posner, Robert Faure et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Barry I. Posner

Since Specialization

Citations

This map shows the geographic impact of Barry I. Posner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry I. Posner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry I. Posner more than expected).

Fields of papers citing papers by Barry I. Posner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry I. Posner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry I. Posner. The network helps show where Barry I. Posner may publish in the future.

Co-authorship network of co-authors of Barry I. Posner

This figure shows the co-authorship network connecting the top 25 collaborators of Barry I. Posner. A scholar is included among the top collaborators of Barry I. Posner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry I. Posner. Barry I. Posner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Insulin Signalling: The Inside Story 2016 ·Canadian Journal of Diabetes ·Barry I. Posner	53
2	Assessment of Internalization and Endosomal Signaling 2014 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Barry I. Posner, John Bergeron	7
3	Global analysis of protein phosphorylation networks in insulin signaling by sequential enrichment of phosphoproteins and phosphopeptides 2012 ·Molecular BioSystems ·(unknown), (unknown), Yanqing Xu, (unknown), Marcos R. DiFalco, (unknown), Ilya E. Nifant’ev, Barry I. Posner, Alexey V. Pshezhetsky	8
4	Cellular Signalling: Peptide Hormones and Growth Factors 2010 ·Progress in brain research ·Barry I. Posner, Stéphane A. Laporte	16
5	Effect of Insulin on Caveolin-enriched Membrane Domains in Rat Liver 2004 ·Journal of Biological Chemistry ·Alejandro Balbis, Gerardo Baquiran, Cathérine Mounier, Barry I. Posner	31
6	Epidermal Growth Factor-induced Phosphatidylinositol 3-Kinase Activation and DNA Synthesis 2000 ·Journal of Biological Chemistry ·(unknown), Cathérine Mounier, Jiong Wu, Barry I. Posner	41
7	Interaction of the Grb10 Adapter Protein with the Raf1 and MEK1 Kinases 1998 ·Journal of Biological Chemistry ·André Nantel, (unknown), (unknown), Barry I. Posner, David Y. Thomas	94
8	Early Signaling Events Triggered by Peroxovanadium [bpV(phen)] Are Insulin Receptor Kinase (IRK)-Dependent: Specificity of Inhibition of IRK-Associated Protein Tyrosine Phosphatase(s) by bpV(phen) 1997 ·Molecular Endocrinology ·(unknown), Barry I. Posner, Víctor Dumas, Jean-Olivier Contrerès	21
9	A role for tyrosine phosphorylation in both activation and inhibition of the insulin receptor tyrosine kinase in vivo. 1996 ·Endocrinology ·Paul G. Drake, A. Paul Bevan, J.W. Burgess, John Bergeron, Barry I. Posner	42
10	Intracellular signal transduction: The role of endosomes 1996 ·Trends in Endocrinology and Metabolism ·A. Paul Bevan, Paul G. Drake, John Bergeron, Barry I. Posner	54
11	Compartmentalized signal transduction by receptor tyrosine kinases 1995 ·Trends in Cell Biology ·(unknown), Gianni M. Di Guglielmo, François‐Jérôme Authier, Barry I. Posner, John Bergeron	124
12	Selective Activation of the Rat Hepatic Endosomal Insulin Receptor Kinase 1995 ·Journal of Biological Chemistry ·A. Paul Bevan, (unknown), Paul G. Drake, Alan Shaver, John Bergeron, Barry I. Posner	72
13	Peroxovanadium compounds: Biolgoical actions and mechanism of insulin-mimesis 1995 ·Molecular and Cellular Biochemistry ·A. Paul Bevan, Paul G. Drake, Jean‐François Yale, Alan Shaver, Barry I. Posner	105
14	Pharmacological doses of insulin equalize insulin receptor phosphotyrosine content but not tyrosine kinase activity in plasmalemmal and endosomal membranes 1992 ·Biochemistry and Cell Biology ·(unknown), A. Paul Bevan, John Bergeron, Barry I. Posner	5
15	A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases 1991 ·Nature ·Shi‐Hsiang Shen, Lison Bastien, Barry I. Posner, Pierre Chrétien	366
16	Hepatic protein phosphotyrosine phosphatase. Dephosphorylation of insulin and epidermal growth factor receptors in normal and alloxan diabetic rats. 1990 ·Journal of Clinical Investigation ·Philip A. Gruppuso, (unknown), Barry I. Posner, Robert Faure, David L. Brautigan	33
17	Determination of insulin and insulin-like growth factors in the ovarian circulation 1990 ·Fertility and Sterility ·(unknown), (unknown), H. Guyda, Barry I. Posner	30
18	Homologous induction of growth hormone receptors in cultured rat hepatocytes 1989 ·Molecular and Cellular Endocrinology ·Itamar Barash, Barry I. Posner	17
19	Insulin and the efficacy of total parenteral nutrition 1989 ·American Journal of Clinical Nutrition ·H.M. Shizgal, Barry I. Posner	15
20	Mannose 6-phosphate increases the affinity of its cation-independent receptor for insulin-like growth factor II by displacing inhibitory endogenous ligands 1988 ·Biochemical and Biophysical Research Communications ·Constantin Polychronakos, H. Guyda, Barry I. Posner	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact